You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
公告精選︱同花順:控股股東易崢、股東凱士順擬合計減持不超138.31萬股;誠達藥業:股東前海晟泰擬減持不超過7.27%公司股份

【熱點

西部黃金(601069.SH):黃金採選和冶煉是本公司主營業務之一

投資】

軟控股份(002073.SZ):控股子公司擬成立合資公司投資生物質電廠項目

東湖高新(600133.SH):控股子公司擬設立合資公司負責長子垃圾焚燒項目

【中標合

東南網架(002135.SZ):聯合體中標13.2億元EPC項目

華康潔淨(301235.SZ):預中標醫療服務建設工程項目

【股權收購

新鳳鳴(603225.SH):擬1.02億元購買賽彌爾的100%股權

沃特股份(002886.SZ):擬以2571.60萬元收購密封件公司100%股權

回購

凌志軟件(688588.SH):累計回購0.9375%股份 完成第二期回購股份

燦瑞科技(688061.SH):董事長提議公司回購2000萬元-4000萬元股份

經營數據

金新農(002548.SZ):8月生豬銷售收入1.21億元

新希望(000876.SZ):8月生豬銷售收入17.22億元

牧原股份(002714.SZ):8月商品豬銷售收入118.5億元

東瑞股份(001201.SZ):8月生豬銷售收入1.60億元

增減持

同花順(300033.SZ):控股股東易崢、股東凱士順擬合計減持不超138.31萬股

利仁科技(001259.SZ):實控人的一致行動人利仁投資擬減持不超3%股份

奧海科技(002993.SZ):吉安奧悅擬減持不超2.57%股份

長江材料(001296.SZ):控股股東、實控人熊鷹擬減持不超3%股份

家聯科技(301193.SZ):鎮海金塑、鎮海金模擬合計減持不超2.6166%股份

誠達藥業(301201.SZ):股東前海晟泰擬減持不超過7.27%公司股份

科拓生物(300858.SZ):股東寧波順懿擬減持不超過790.48萬股股份

畢得醫藥(688073.SH):股東舟山欣曦、寧波蘭旦及其一致行動人擬合計減持不超2.86%股份

其他

天成自控(603085.SH):子公司收到客戶項目定點通知

ST嶺南(002717.SZ):因涉嫌信息披露違法違規 公司及原控股股東收到證監會立案告知書

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account